CS Diagnostics Corp.
Other OTCTotal Valuation
CS Diagnostics Corp. carries a market capitalization of 7.25M, placing it among publicly traded companies globally. Its enterprise value stands at -37,378.00, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 7.25M |
| Enterprise Value | -37,378.00 |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | -1.83M |
| P/OCF Ratio | -1.83M |
Financial Position
CS Diagnostics Corp. maintains a current ratio of 0.02, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -579.63 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
CS Diagnostics Corp.'s stock has declined approximately -83.13953% over the past 52 weeks. The 50-day moving average sits at 0.05, while the 200-day moving average is 0.14.
| Beta (5Y) | N/A |
| 52-Week Price Change | -83.13953% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.14 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -297,493.00, while operating income came in at -298,050.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -298,050.00 |
| Pretax Income | -274,163.00 |
| Net Income | -341,612.00 |
| EBITDA | -297,493.00 |
| EBIT | -298,050.00 |
| Earnings Per Share (EPS) | -341,612.00 |
Balance Sheet
Total book value stands at -1.95M, with working capital of -1.98M providing operational flexibility.
| Cash & Cash Equivalents | 37,378.00 |
| Total Debt | N/A |
| Net Debt | -37,378.00 |
| Equity (Book Value) | -1.95M |
| Book Value Per Share | N/A |
| Working Capital | -1.98M |
Cash Flow
CS Diagnostics Corp. produced -104.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -104.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -104.00 |
| FCF Per Share | -104.00 |
Stock Splits
CS Diagnostics Corp.'s most recent stock split took place on August 3, 2023 with a 500:1 split ratio.
| Last Split Date | 8/3/2023 |
| Split Ratio | 500:1 |
Scores
CS Diagnostics Corp. posts an Altman Z-Score of -203.41, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -203.41 |